A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts (Q38150728)

29 August 2017

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts (English)

1 reference

29 August 2017

1 reference

1 reference

Arunaloke Chakrabarti

3

Arunaloke Chakrabarti

1 reference

29 August 2017

Carlo Tascini

15

0 references

Jose Garnacho-Montero

Jose Garnacho-Montero

5

0 references

Emmanuel Roilides

12

Emmanuel Roilides

1 reference

29 August 2017

14

Thomas J Walsh

1 reference

29 August 2017

7

Patricia Munoz

1 reference

29 August 2017

10

Pierluigi Viale

1 reference

29 August 2017

16

Mario Tumbarello

1 reference

29 August 2017

1

Matteo Bassetti

1 reference

Francesco Giuseppe De Rosa

29 August 2017

24

Francesco Giuseppe De Rosa

1 reference

29 August 2017

20

Claudio Viscoli

1 reference

29 August 2017

8

Francesco Cristini

1 reference

29 August 2017

18

Elda Righi

1 reference

29 August 2017

19

Christian Eckmann

1 reference

29 August 2017

Monia Marchetti

2

1 reference

29 August 2017

Sergio Colizza

4

1 reference

29 August 2017

Daniel H Kett

6

1 reference

29 August 2017

Anastasia Andoniadou

9

1 reference

29 August 2017

Giorgio Della Rocca

11

1 reference

29 August 2017

Gabriele Sganga

13

1 reference

29 August 2017

Francesco Menichetti

17

1 reference

29 August 2017

Andrew F Shorr

21

1 reference

29 August 2017

Olivier Leroy

22

1 reference

29 August 2017

George Petrikos

23

1 reference

29 August 2017

9 October 2013

1 reference

29 August 2017

Intensive Care Medicine

1 reference

29 August 2017

39

1 reference

29 August 2017

2092-2106

1 reference

29 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-013-3109-3

29 August 2017

0 references

cites work

Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

European expert opinion on the management of invasive candidiasis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

New approaches to the risk of Candida in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

A scoring model of factors associated with Candida glabrata candidemia among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Risk factors for fluconazole-resistant candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Candida infection and colonization among trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Clinical significance of Candida isolated from peritoneum in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Invasive candidiasis in ICU: analysis of antifungal treatments in the French study AmarCand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Antifungal susceptibility testing: practical aspects and current challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

New nonculture-based methods for the diagnosis of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Rapid identification of Candida spp. in peritonitis patients by Raman spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Treatment of invasive candidal infections: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Amphotericin B still in the headlines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3109-3

New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis

21 January 2018

1 reference

12 December 2020

Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy

1 reference

12 December 2020

Development of quality indicators: lessons learned in bariatric surgery

1 reference

12 December 2020

Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

1 reference

12 December 2020

Surgical re-intervention in postoperative peritonitis based on longitudinal scoring systems

1 reference

12 December 2020

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis

1 reference

12 December 2020

Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome

1 reference

12 December 2020

Diagnostic methods in candidemia: a systematic review of literature with meta-analysis

1 reference

12 December 2020

Prophylactic fluconazole does not improve outcome in patients with purulent and fecal peritonitis due to lower gastrointestinal perforation.

1 reference

12 December 2020

Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection

1 reference

12 December 2020

Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?

1 reference

12 December 2020

Candida as a risk factor for mortality in peritonitis

1 reference

12 December 2020

Effect of Candida infection on outcome in patients with perforation peritonitis.

1 reference

12 December 2020

Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species

1 reference

12 December 2020

Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis

1 reference

12 December 2020

Consensus development methods, and their use in clinical guideline development

1 reference

12 December 2020

Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

10.1007/S00134-013-3109-3

Identifiers

DOI

1 reference

29 August 2017

1 reference